Your basket is currently empty!
Catalog List
Catalog List
ProM2® MHC Class II Monomers, biotinylated
Tetramers/Monomers by Research Area:
| Allergy | Aspergillus | Autoimmunity | 
| Bordetella Pertussis | Cancer | CMV | 
| COVID-19 / SARS-CoV-2 | EBV | Factor VIII | 
| HBV | HCV | HIV | 
| HPV | Influenza | Malaria | 
| Multiple Sclerosis | Tetanus | Therapeutic Antibodies | 
| Tuberculosis | Negative | Helicobacter pylori | 
| LCMV | Listeria | Model Antigens / Other | 
| RSV | West Nile Virus | 
Search the table below by disease, allele, specificity or sequence, or any combination, e.g. “Cancer NY-ESO DRB1*04:01”.
| Research Area | Allele | Peptide Code | Peptide Sequence | Epitope Origin | 
|---|---|---|---|---|
| Allergy | DRB1*01:01 | 3137 | DSVTPMILKAQKGGNL | Dog dander Can f 1 33-48 | 
| Allergy | DRB1*01:01 | 3147 | KCIEWEKAQHGA | Mugwort pollen Art v 1 25-36 | 
| Allergy | DRB1*01:01 | 3152 | LPVVLENARILKNCVDAK | Cat dander Fel d 1 53-70 | 
| Allergy | DRB1*01:01 | 3153A | LRQMRTVTPIRMQGG | House dust mite Der p1 96-110 | 
| Allergy | DRB1*01:01 | 3163A | VAAAPQVKYAVFEAALTKAI | Timothy grass Phl p 5 p26 | 
| Allergy | DRB1*01:01 | 2899 | YESYKFIPALEAAVK | Grass pollen allergen Phl p 5 196-210 | 
| Allergy | DRB1*01:01 | 2898A | ETLLRAVESYLLAHS | Birch pollen allergen Bet v 1 142-156 | 
| Allergy | DRB1*04:01 | 3131 | APYHFDLSGHAFG | Rye grass Lol p1 124-136 | 
| Allergy | DRB1*04:01 | 3139 | ELEKYQQLNSERGVPN | Cow dander Bos d 2 143-158 | 
| Allergy | DRB1*04:01 | 2898C | ETLLRAVESYLLAHS | Birch pollen allergen Bet v 1 141-155 | 
| Allergy | DRB1*04:01 | 3163B | VAAAPQVKYAVFEAALTKAI | Timothy grass Phl p 5 p26 | 
| Allergy | DRB1*07:01 | 3136 | DRVNFKYSFSVIE | Alder pollen Aln g 1 76-88 | 
| Allergy | DRB1*07:01 | 3163C | VAAAPQVKYAVFEAALTKAI | Timothy grass Phl p 5 p26 | 
| Allergy | DRB1*07:01 | 3164A | VGLLKAVESYLLA | Alder pollen Aln g 1 142-154 | 
| Allergy | DRB1*09:01 | 3163D | VAAAPQVKYAVFEAALTKAI | Timothy grass Phl p 5 p26 | 
| Allergy | DRB1*11:01 | 3151 | LEAAFNAEFNEIRRVLLEEN | Peanut Ara h 1 321-340 | 
| Allergy | DRB1*11:01 | 3161 | TSRNNPFYFPSRRFSTRYGN | Peanut Ara h 1 169-188 | 
| Allergy | DRB1*11:01 | 3165 | VVNKGTGNLELVAVRKEQQQ | Peanut Ara h 1 457-476 | 
| Allergy | DRB1*11:01 | 3163E | VAAAPQVKYAVFEAALTKAI | Timothy grass Phl p 5 p26 | 
| Allergy | DRB1*15:01 | 3163F | VAAAPQVKYAVFEAALTKAI | Timothy grass Phl p 5 p26 | 
| Allergy | DRB1*15:01 | 3164B | VGLLKAVESYLLA | Alder pollen Aln g 1 142-154 | 
| Allergy | DRB1*15:01 | 3134 | AVNIVGYSNAQGVDY | House dust mite Der p1 251-265 | 
| Allergy | DRB1*15:01 | 2898B | ETLLRAVESYLLAHS | Birch pollen allergen Bet v 1 142-156 | 
| Allergy | DRB1*15:01 | 3153B | LRQMRTVTPIRMQGG | House dust mite Der p1 96-110 | 
| Aspergillus | DRB1*03:01 | 3145 | HTYTIDWTKDAVTWS | Aspergillus fumigatus Crf1/p41 171-185 | 
| Aspergillus | DRB1*04:01 | 2858 | FHTYTIDWTKDAVTW | Aspergillus fumigatus Crf1/p41 170-184 | 
| Autoimmunity | DRB1*03:01 | 2950 | SLQPLALEGSLQKRG | Insulin Precursor 76-90 | 
| Autoimmunity | DRB1*03:01 | 3043 | TVYGAFDPLLAVAD | GAD2 339-352 | 
| Autoimmunity | DRB1*04:01 | 1941 | NFIRMVISNPAAT | GAD65 555-567 | 
| Autoimmunity | DRB1*04:01 | 2701 | IAFTSEHSHFSLK | GAD65 274-286 | 
| Autoimmunity | DRB1*04:01 | 2734 | GAGSLQPLALEGSLQKRG | Proinsulin 73-90 | 
| Autoimmunity | DRB1*04:01 | 2897 | GIVEQCCTSICSLYQ | Proinsulin 90-104 | 
| Autoimmunity | DRB1*04:01 | 2951 | SLQPLALEGSLQSRG | Preproinsulin 76-90 88S | 
| Autoimmunity | DRB1*04:01 | 3132 | ATEG[cit]V[cit]VNSAYQDK | Cit aggregan 89-103 | 
| Autoimmunity | DRB1*04:01 | 3133 | ATIKAEFV[cit]AETPYM | Cit CILP 297?311 | 
| Autoimmunity | DRB1*04:01 | 3138 | DVMNILLQYVVKSFDRSTKV | GAD65 113-132 | 
| Autoimmunity | DRB1*04:01 | 3143 | GKLYGI[cit]DV[cit]STRDR | Cit CILP 982?996 | 
| Autoimmunity | DRB1*04:01 | 3144 | GVYAT[cit]SSAV[cit]L[cit]SSVPGVR | Cit vimentin aa 59-78 | 
| Autoimmunity | DRB1*04:01 | 3146 | IFDS[cit]GNPTVEVDLF | Cit alpha-enolase 11-25 | 
| Autoimmunity | DRB1*04:01 | 3148 | KGMAALPRLIAFTSEHSHFS | GAD65 265?284 | 
| Autoimmunity | DRB1*04:01 | 3157 | QDFTN[cit]INKLKNS | Cit fibrinogen-alpha 79-91 | 
| Autoimmunity | DRB1*15:01 | 1912 | DENPVVHFFKNIVTPRTPP | Myelin basic protein 83-101 | 
| Autoimmunity | H-2 IAb | 423 | NAGFNSNRANSSRSS | DBY 608-622 | 
| Autoimmunity | H-2 IAb | 3955 | GEPGIAGFKGEQGPK | Type II collagen (CII) 256-270 | 
| Autoimmunity | H-2 IAg7 | 4273 | SPGDLQTLALEVARQKRG | mouse ProInsulin 47-64 | 
| Bordetella Pertussis | DRB1*07:01 | 3167 | YYSNVTATRLLSSTNS | Pertussis toxin subunit 2 129-144 | 
| Cancer | DRB1*01:01 | 3092 | GWVKPIIIGHHAYGDQYRAT | isocitrate dehydrogenase [NADP] cytoplasmic (IDH1)(123-142) | 
| Cancer | DRB1*01:01 | 2844 | KSVWSKLQSIGIRQH | TERT UPC2 (578-592) | 
| Cancer | DRB1*01:01 | 2733 | ACYEFLWGPRALVETS | MAGE-A3 267-282 | 
| Cancer | DRB1*01:01 | 2712A | LKEFTVSGNILTIRL | NY-ESO-1 123-137 | 
| Cancer | DRB1*01:01 | 2736A | LLEFYLAMPFATPME | NY-ESO-1 87-101 | 
| Cancer | DRB1*01:01 | 2894A | KVPIKWMALESILRRRF | HER2 883-899 | 
| Cancer | DRB1*04:01 | 479 | WNRQLYPEWTEAQRLD | gp100 44-59 | 
| Cancer | DRB1*04:01 | 1945 | ISPNSVFSQWRVVCDSLEDYD | Tyrp1 277-297 | 
| Cancer | DRB1*04:01 | 2888 | ESEFQAALSRKVAKL | MAGE-A6 102-116 | 
| Cancer | DRB1*04:01 | 2889 | LTQYFVQENYLEYRQVPG | MAGE-A6 246-263 | 
| Cancer | DRB1*04:01 | 2890 | YACFVSNLATGRNNS | CEA 653-667 | 
| Cancer | DRB1*04:01 | 2891 | NYTLRVDCTPLMYSL | PSMA 459-473 | 
| Cancer | DRB1*04:01 | 2892 | IYRRRLMKQDFSVPQLPHS | gp100 615-633 | 
| Cancer | DRB1*04:01 | 2893 | ALHIYMDGTMSQVQGSA | tyrosinase 365-381 | 
| Cancer | DRB1*04:01 | 2895 | RNGYRALMDKSLHVGTQCALTRR | MART-1 51-73 | 
| Cancer | DRB1*04:01 | 2712B | LKEFTVSGNILTIRL | NY-ESO-1 123-137 | 
| Cancer | DRB1*04:01 | 2736B | LLEFYLAMPFATPME | NY-ESO-1 87-101 | 
| Cancer | DRB1*04:01 | 2894B | KVPIKWMALESILRRRF | HER2 883-899 | 
| Cancer | DRB1*04:05 | 3215 | LWWVNNQSLPVSP | CEA 321-333ÿ | 
| Cancer | DRB1*09:01 | 2736C | LLEFYLAMPFATPME | NY-ESO-1 87-101 | 
| Cancer | DRB1*11:01 | 2887 | TSYVKVLHHMVKISG | MAGE-A3 281-295 | 
| Cancer | H-2 IAb | 4117 | SGHNCGTCRPGWRGAACNQKILTVR | Tyrosinase-related protein 1 1106-130 | 
| CMV | DRB1*01:01 | 1126 | LPLKMLNIPSINVH | CMV pp65 116-129 | 
| CMV | DRB1*07:01 | 2720 | EPDVYYTSAFVFPTK | CMV pp65 177-191 | 
| CMV | DRB1*07:01 | 2721 | PDDYSNTHSTRYVTV | CMV gB 215-229 | 
| CMV | DRB1*15:01 | 1942 | MSIYVYALPLKMLNI | CMV pp65 109-123 | 
| COVID-19 / SARS-CoV-2 | DRB1*01:01 | 4407 | TSRTLSYYKLGASQRVA | SARS-CoV-2 Membrane glycoprotein 172-188? | 
| COVID-19 / SARS-CoV-2 | DRB1*01:01 | 4683A | TRFQTLLALHRSYLT | SARS-CoV-2 Spike 236-250 | 
| COVID-19 / SARS-CoV-2 | DRB1*01:01 | 4702A | FYVYSRVKNLNSSRV | SARS-CoV-2 Env 56-70 | 
| COVID-19 / SARS-CoV-2 | DRB1*01:01 | 4703A | LEASFNYLKSPNFSK | SARS-CoV-2 ORF1ab 2211-2225 | 
| COVID-19 / SARS-CoV-2 | DRB1*01:01 | 4704A | LSYYKLGASQRVAGD | SARS-CoV-2 gp 176-190 | 
| COVID-19 / SARS-CoV-2 | DRB1*01:01 | 4705A | SEFSSLPSYAAFATA | SARS-CoV-2 ORF1ab 3948-3962 | 
| COVID-19 / SARS-CoV-2 | DRB1*04:01 | 4683B | TRFQTLLALHRSYLT | SARS-CoV-2 Spike 236-250 | 
| COVID-19 / SARS-CoV-2 | DRB1*04:01 | 4702B | FYVYSRVKNLNSSRV | SARS-CoV-2 Env 56-70 | 
| COVID-19 / SARS-CoV-2 | DRB1*04:01 | 4703B | LEASFNYLKSPNFSK | SARS-CoV-2 ORF1ab 2211-2225 | 
| COVID-19 / SARS-CoV-2 | DRB1*04:01 | 4704B | LSYYKLGASQRVAGD | SARS-CoV-2 gp 176-190 | 
| COVID-19 / SARS-CoV-2 | DRB1*04:01 | 4705B | SEFSSLPSYAAFATA | SARS-CoV-2 ORF1ab 3948-3962 | 
| COVID-19 / SARS-CoV-2 | DRB1*15:01 | 4405 | NLLLQYGSFCTQLNR | SARS-CoV-2 Spike glycoprotein 751-765 | 
| COVID-19 / SARS-CoV-2 | DRB1*15:01 | 4406 | TDEMIAQYTSALLAG | SARS-CoV-2 Spike glycoprotein 866-880 | 
| COVID-19 / SARS-CoV-2 | DRB1*15:01 | 4414 | NLLLQYGSFCTQLNRAL | SARS-CoV-2 Spike glycoprotein 751-767 | 
| COVID-19 / SARS-CoV-2 | DRB1*15:01 | 4683C | TRFQTLLALHRSYLT | SARS-CoV-2 Spike 236-250 | 
| COVID-19 / SARS-CoV-2 | DRB1*15:01 | 4702C | FYVYSRVKNLNSSRV | SARS-CoV-2 Env 56-70 | 
| COVID-19 / SARS-CoV-2 | DRB1*15:01 | 4703C | LEASFNYLKSPNFSK | SARS-CoV-2 ORF1ab 2211-2225 | 
| COVID-19 / SARS-CoV-2 | DRB1*15:01 | 4704C | LSYYKLGASQRVAGD | SARS-CoV-2 gp 176-190 | 
| COVID-19 / SARS-CoV-2 | DRB1*15:01 | 4705C | SEFSSLPSYAAFATA | SARS-CoV-2 ORF1ab 3948-3962 | 
| COVID-19 / SARS-CoV-2 | DRB1*01:01 | 4329 | GAALQIPFAMQMAYRF | SARS-CoV S protein (873-888) (conserved in SARS-CoV-2) | 
| COVID-19 / SARS-CoV-2 | DRB1*01:01 | 4330 | MAYRFNGIGVTQNVLY | SARS-CoV S protein (884-899) (conserved in SARS-CoV-2) | 
| COVID-19 / SARS-CoV-2 | DRB1*01:01 | 4331A | QLIRAAEIRASANLAATK | SARS-CoV S protein (993-1010) (conserved in SARS-CoV-2) | 
| COVID-19 / SARS-CoV-2 | DRB1*03:01 | 464 | CTFEYVSQPFLMDLE | SARS-CoV2 Spike Protein (S) 166-180 | 
| COVID-19 / SARS-CoV-2 | DRB1*04:01 | 4332 | QALNTLVKQLSSNFGAI | SARS-CoV S protein (939-955)(conserved in SARS-CoV-2) | 
| COVID-19 / SARS-CoV-2 | DRB1*04:01 | 4331B | QLIRAAEIRASANLAATK | SARS-CoV S protein (993-1010) (conserved in SARS-CoV-2) | 
| EBV | DRB1*01:01 | 1940 | TVFYNIPPMPL | EBV EBNA2 280-290 | 
| EBV | DRB1*01:01 | 2738 | TSLYNLRRGTALA | EBV EBNA1 515-527 | 
| EBV | DRB1*04:01 | 822 | PYYVVDLSVRGM | EBV BHRF1 122-133 | 
| EBV | DRB1*04:01 | 2702 | AEGLRALLARSHVER | EBV EBNA1 482-496 | 
| EBV | DRB1*04:01 | 2882 | GQTYHLIVDTDSLGNPSLSV | EBV EBNA2 11-30 | 
| EBV | DRB1*07:01 | 2723 | VPGLYSPCRAFFNKEELL | EBV MCP 1264-1281 | 
| EBV | DRB1*07:01 | 2735 | PGPLRESIVCYFMVFLQTHI | EBV EBNA1 551-570 | 
| EBV | DRB1*07:01 | 2883 | VYGGSKTSLYNLRRGTALAI | EBV EBNA1 509-528 | 
| EBV | DRB1*07:01 | 2884 | PRSPTVFYNIPPMPLPPSQL | EBV EBNA2 276-295 | 
| Factor VIII | DRB1*11:01 | 3140 | ENIQRFLPNPAGVQLEDPEF | Factor VIII 589-608 | 
| Factor VIII | DRB1*15:01 | 4333 | TLFFQNGKVKVFQGNQDSFT | Factor VIII 2291–2310 | 
| Factor VIII | H-2 IAb | 4118 | TASSYFTNMFATWSPSKARL | Human clotting factor VIII 2210-2229 | 
| HBV | DRB1*01:01 | 2691 | QAGFFLLTRILTIPQS | HBV envelope 179-194 | 
| HBV | DRB1*01:01 | 2699 | PPAYRPPNAPILSTL | HBV core 158-172 | 
| HBV | DRB1*01:01 | 2739 | LCWGELMTLATWVGVN | HBV core 60-75 | 
| HBV | DRB1*04:01 | 2722 | LSFLPSDFFPSVRDL | HBV core 45-59 | 
| HCV | DRB1*01:01 | 2690 | TLLFNILGGWVAA | HCV polyprotein 1806?1818, NS4b | 
| HCV | DRB1*03:01 | 2703 | VYYLTRDPTTPLARAA | HCV polyprotein 2800-2815, NS5b | 
| HCV | DRB1*04:01 | 549 | GYKVLVLNPSVAATL | HCV polyprotein 1248-1262, NS3 | 
| HCV | DRB1*04:01 | 2693 | SGIQYLAGLSTLPGNPAIASL | HCV polyprotein 1770-1790, NS4b | 
| HCV | DRB1*07:01 | 3135 | AYCLWMMLLISQAEAALELIT | HCV NS2 732-753 | 
| HCV | DRB1*07:01 | 3166 | WPLLLLLLALPQRAYAQ | HCV NS2 47-63 | 
| HCV | DRB1*07:01 | 4295 | SLTITSLLRRHNWITSCS | HCV NS5a 1957-1975 | 
| HCV | DRB1*07:01 | 4294A | TTVRLRAYMNTPGLPVC | HCV NS3 1535-1551 | 
| HCV | DRB1*15:01 | 2715 | NFPYLVAYQATVCARA | HCV polyprotein 1582-1597, NS3 | 
| HCV | DRB1*15:01 | 2727 | GINAVAYYRGLDVSV | HCV polyprotein 1411-1425, NS3 | 
| HCV | DRB1*15:01 | 4294B | TTVRLRAYMNTPGLPVC | HCV NS3 1535-1551 | 
| Helicobacter pylori | H-2 IAb | 4119 | GNAYISVLAHYGKNG | Helicobacter hepaticus HH1713 230-244 | 
| HIV | DRB1*01:01 | 2741 | DYVDRFYKTLRAE | HIV-1 gag 295-307 | 
| HIV | DRB1*01:01 | 2742 | KRWIILGLNKIVRMYSPTSI | HIV-1 gag 263-282 | 
| HIV | DRB1*01:01 | 2718A | FRDYVDRFYKTLRAEQASQE | HIV-1 gag 293-312 | 
| HIV | DRB1*04:01 | 2706 | AFSPEVIPMFSALSEGATPQ | HIV-1 gag 163-182 | 
| HIV | DRB1*07:01 | 2718B | FRDYVDRFYKTLRAEQASQE | HIV-1 gag 293-312 | 
| HIV | DRB1*11:01 | 2718C | FRDYVDRFYKTLRAEQASQE | HIV-1 gag 293-312 | 
| HPV | DRB1*03:01 | 2737 | PIVQLQGDSNCLKCFR | HPV E2 285-300 | 
| HPV | DRB1*03:01 | 3155 | MEAIAKRLDACQDQLLELYE | HPV E2 1-20 | 
| Influenza | DRB1*01:01 | 2717 | SGPLKAEIAQRLEDV | Influenza A MP 17-31 | 
| Influenza | DRB1*01:01 | 357A | PKYVKQNTLKLAT | Influenza A HA 307-319 | 
| Influenza | DRB1*04:01 | 2705 | FWRGENGRKTRIAYERMCNILKGK | Influenza A NP 206-229 | 
| Influenza | DRB1*04:01 | 2729 | GFVFTLTVPSER | Influenza A MP 61-72 | 
| Influenza | DRB1*04:01 | 357B | PKYVKQNTLKLAT | Influenza A HA 307-319 | 
| Influenza | DRB1*04:02 | 357F | PKYVKQNTLKLAT | Influenza A HA 307-319 | 
| Influenza | DRB1*04:05 | 357E | PKYVKQNTLKLAT | Influenza A HA 307-319 | 
| Influenza | DRB1*07:01 | 357C | PKYVKQNTLKLAT | Influenza A HA 307-319 | 
| Influenza | DRB1*11:01 | 357D | PKYVKQNTLKLAT | Influenza A HA 307-319 | 
| Influenza | H-2 IAb | 3029 | QVYSLIRPNENPAHK | Influenza A nucleocapsid protein 311-325 | 
| Influenza | H-2 IAd | 4268 | HNTNGVTAACSHE | IAd Influenza A HA 143-155 | 
| Influenza | H-2 IAd | 4269 | RGHNVNGVTAACSHE | IAd Influenza A HA 141-155 | 
| Influenza | H-2 IAd | 4270 | SLLTEVETPIRNEWGS | IAd Influenza A M2 2-17 | 
| LCMV | H-2 IAb | 3023 | DIYKGVYQFKSV | Lymphocytic choriomeningitis virus glycoprotein 66-77 | 
| LCMV | H-2 IAb | 4122 | TMFEALPHIIDEVIN | Lymphocytic choriomeningitis virus glycoprotein 6-20 | 
| LCMV | H-2 IAd | 4123 | CDMLRLIDYNKAALS | Lymphocytic choriomeningitis virus glycoprotein 316-330 | 
| LCMV | H-2 IAd | 4124 | PSLTMACMAKQSQTP | Lymphocytic choriomeningitis virus nucleoprotein 176-190 | 
| LCMV | H-2 IAd | 4125 | SQNRKDIKLIDVEMT | Lymphocytic choriomeningitis virus nucleoprotein 466-480 | 
| LCMV | H-2 IAd | 4271 | KNVLKVGRLSAEELM | IAd LCMV NP 86-100 | 
| LCMV | H-2 IAd | 4272 | SERPQASGVYMGNLT | IAd LCMV NP 116-130 (P8) | 
| Listeria | H-2 IAb | 3028 | NEKYAQAYPNVS | Listeriolysin O precursor 190-201 | 
| Malaria | DRB1*01:01 | 2896A | EYLNKIQNSLSTEWSPCSVT | CSP 326-345 | 
| Malaria | DRB1*04:01 | 2896B | EYLNKIQNSLSTEWSPCSVT | CSP 326-345 | 
| Malaria | DRB1*07:01 | 2896C | EYLNKIQNSLSTEWSPCSVT | CSP 326-345 | 
| Model Antigens / Other | H-2 IAb | 1010 | ISQAVHAAHAEINEAGR | Chicken ovalbumin 323-339 | 
| Model Antigens / Other | H-2 IAb | 3024 | EAWGALANWAVDSA | I-E alpha chain (2W1S) 52-68 | 
| Model Antigens / Other | H-2 IAb | 3223B | AAHAEINEA | Chicken ovalbumin 329-337 | 
| Model Antigens / Other | H-2 IAd | 3223A | AAHAEINEA | Chicken ovalbumin 329-337 | 
| Model Antigens / Other | H-2 IAg7 | 4894 | AHHPIWARMDA | Mimotope of Chain A, Histocompatibility Antigen I-Ag7 from Mus Musculus Chain A. | 
| Multiple Sclerosis | DRB1*03:01 | 3159 | RQIFGDYKTTIC | PLP 98-109 | 
| Multiple Sclerosis | DRB1*04:01 | 2963 | RTELLKDAIGEGK | MOG 97-109 | 
| Multiple Sclerosis | DRB1*04:01 | 3162 | TWTTCQSIAFPSKTSASIGS | PLP 180-199 | 
| Multiple Sclerosis | H-2 IAb | 2958 | GWYRSPFSRVVH | Mouse myelin oligodendrocyte glycoprotein 38-49 | 
| Multiple Sclerosis | H-2 IAb | 4131 | TTHYGSLPQKSQ | Mouse MBP 63-74 | 
| Multiple Sclerosis | H-2 IAb | 4186 | GWYRPPFSRVVH | MOG 38-49 var S42P | 
| Multiple Sclerosis | H-2 IAb | 4187 | GWYRSPFSRAVH | MOG 38-49 var V47A | 
| Negative Control / CLIP | DRB1*01:01 | N02A | PVSKMRMATPLLMQA | CLIP 87-101 | 
| Negative Control / CLIP | DRB1*03:01 | N02B | PVSKMRMATPLLMQA | CLIP 87-101 | 
| Negative Control / CLIP | DRB1*04:01 | N02C | PVSKMRMATPLLMQA | CLIP 87-101 | 
| Negative Control / CLIP | DRB1*04:02 | N02I | PVSKMRMATPLLMQA | CLIP 87-101 | 
| Negative Control / CLIP | DRB1*04:05 | N02H | PVSKMRMATPLLMQA | CLIP 87-101 | 
| Negative Control / CLIP | DRB1*07:01 | N02D | PVSKMRMATPLLMQA | CLIP 87-101 | 
| Negative Control / CLIP | DRB1*09:01 | N02G | PVSKMRMATPLLMQA | CLIP 87-101 | 
| Negative Control / CLIP | DRB1*11:01 | N02E | PVSKMRMATPLLMQA | CLIP 87-101 | 
| Negative Control / CLIP | DRB1*15:01 | N02F | PVSKMRMATPLLMQA | CLIP 87-101 | 
| Negative Control / CLIP | H-2 IAb | N02J | PVSQMRMATPLLMRP | Murine class II-associated invariant chain peptide (CLIP) 86-100 | 
| Negative Control / CLIP | H-2 IAb | N02K | PVSKMRMATPLLMQA | Human class II-associated invariant chain peptide (CLIP) 103-117 | 
| Negative Control / CLIP | H-2 IAd | N02M | PVSQMRMATPLLMRP | Murine class II-associated invariant chain peptide (CLIP) 86-100 | 
| Negative Control / CLIP | H-2 IAg7 | N02L | PVSQMRMATPLLMRP | Murine class II-associated invariant chain peptide (CLIP) 86-100 | 
| RSV | H-2 IAb | 4132 | NKGAFKYIKPQSQFI | Respiratory syncytial virus matrix protein M 209-223 | 
| RSV | H-2 IAb | 4133 | NYFEWPPHALLVRQ | Respiratory syncytial virus matrix protein 2 26-39 | 
| Tetanus | DRB1*01:01 | 3158 | QEIYMQHTYPISA | TT 257-269 | 
| Tetanus | DRB1*11:01 | 2716 | VSIDKFRIFCKALNPK | TT 1084-1099 | 
| Tetanus | DRB1*11:01 | 2719 | FNNFTVSFWLRVPKVSASHLE | TT 947-967 | 
| Tetanus | DRB1*11:01 | 2728 | KFIIKRYTPNNEIDSF | TT 1174-1189 | 
| Tetanus | DRB1*11:01 | 2740 | QYIKANSKFIGITEL | TT 830-844 | 
| Therapeutic Antibodies | DRB1*04:01 | 3243A | SSPKPWIYATSNLAS | Rituximab Light chain 41-55 | 
| Therapeutic Antibodies | DRB1*07:01 | 3242A | WVKQTPGRGLEWIGA | Rituximab Heavy chain 36-50 | 
| Therapeutic Antibodies | DRB1*07:01 | 3243B | SSPKPWIYATSNLAS | Rituximab Light chain 41-55 | 
| Therapeutic Antibodies | DRB1*07:01 | 3244A | EWVAEIRSKSINSAT | Infliximab Heavy chain 46-60 | 
| Therapeutic Antibodies | DRB1*11:01 | 3242B | WVKQTPGRGLEWIGA | Rituximab Heavy chain 36-50 | 
| Therapeutic Antibodies | DRB1*15:01 | 3243C | SSPKPWIYATSNLAS | Rituximab Light chain 41-55 | 
| Therapeutic Antibodies | DRB1*15:01 | 3244B | EWVAEIRSKSINSAT | Infliximab Heavy chain 46-60 | 
| Tuberculosis | DRA1*04:01 | 4250 | EISTNIRQAGVQYSR | M. tuberculosis CFP-10 71-85 | 
| Tuberculosis | DRB1*01:01 | 2902 | GEEYLILSARDVLAV | Mtb 10 kDa chaperonin GroES | 
| Tuberculosis | DRB1*03:01 | 3115 | MAKTIAYDEEARR | Mtb groEL 1-13 | 
| Tuberculosis | DRB1*03:01 | 3149 | KTIAYDEEARR | Mtb groEL 3-13 | 
| Tuberculosis | DRB1*09:01 | 3156 | MTEQQWNFAGIEAAA | Mtb ESAT6 1-15 | 
| Tuberculosis | DRB1*15:01 | 2900 | MHVSFVMAYPEMLAA | Mtb PE family protein | 
| Tuberculosis | DRB1*15:01 | 2901 | MSQIMYNYPAMMAHA | Mtb ESAT-6 like protein | 
| Tuberculosis | H-2 IAb | 3027 | FQDAYNAAGGHNAVF | M. tuberculosis antigen 85B precursor 280-294 | 
| Tuberculosis | H-2 IAb | 4135 | KAAGLFNAPASQLAR | M. tuberculosis RplJ 140-164 | 
| Tuberculosis | H-2 IAb | 4136 | MTEQQWNFAGIEAAASAIQG | ESAT-6 | 
| West Nile Virus | H-2 IAb | 4137 | PVGRLVTVNPFVSVA | West Nile Virus envelope protein 641-655 | 
